Transforming growth factor α is a target for the von Hippel-Lindau tumor suppressor

Cancer Research

Volumn 58, Issue 2, 1998, Pages 226-231

  Knebelmann, Bertrand ^a   Ananth, Subbian ^a   Cohen, Herbert T ^a   Sukhatme, Vikas P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN STABILITY; RNA METABOLISM; TUMOR SUPPRESSOR GENE;

BLOTTING, NORTHERN; CARCINOMA, RENAL CELL; CELLS, CULTURED; DOWN-REGULATION; GENES, TUMOR SUPPRESSOR; HALF-LIFE; HUMANS; KIDNEY NEOPLASMS; LIGASES; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0031964099     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Linehan, W. M., Lerman, M. L., and Zbar, B. Identification of the von Hippel-Lindau (VHL) gene. J. Am. Med. Assoc., 273: 564-570, 1995.
2. Krumm, A., and Groudine, M. Tumor suppression and transcription elongation: the dire consequences of changing partners. Science (Washington DC), 269: 1400-1401, 1995.
3. Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Ananth, S., and Sukhatme, V. P. The von Hippel-Lindau (VHL) tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor (VEGF) promoter activity. Mol. Cell. Biol., 17: 5629-5639, 1997.
4. Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny-Baron, G., and Marme, D. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res., 56: 2299-2301, 1996.
5. Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., and Linehan, W. M. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA, 93: 10589-10594, 1996.
6. Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., Jr., and Goldberg, M. A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA, 93: 10595-10599, 1996.
7. Steiner, M. S. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J. Urol., 153: 1085-1096, 1995.
8. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
9. Petrides, P. E., Bock, S., Bovens, J., Hofmann, R., and Jakse, G. Modulation of pro-epidermal growth factor, pro-transforming growth factor α and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res., 50: 3934-3939, 1990.
10. Humes, H. D., Beals, T. F., Cieslinski, D. A., Sanchez, I. O., and Page, T. P. Effects of transforming growth factor-β, transforming growth factor-α, and other growth factors on renal proximal tubule cells. Lab. Invest., 64: 538-545, 1991.
11. Atlas, I., Mendelsohn, J., Baselga, J., Fair, W. R., Masui, H., and Kumar, R. Growth regulation of human renal carcinoma cells: role of transforming growth factor α. Cancer Res., 52: 3335-3339, 1992.
12. Lee, D. C., Fenton, S. E., Berkowitz, E. A., and Hissong, M. A. Transforming growth factor alpha: expression, regulation, and biological activities. Pharmacol. Rev., 17: 51-85, 1995.
13. Iliopoulos, O., Kibel, A., Gray, S., and Kaelin, W. G. J. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med., 1: 822-826, 1995.
14. Baselga, J., Mendelsohn, J., Kim, Y-M., and Pandiella, A. Autocrine regulation of membrane transforming growth factor-α cleavage. J. Biol. Chem., 271: 3279-3284, 1996.
15. Wong, S. T., Winchell, L. F., McCune, B. K., Earp, H. S., Teixido, J., Massagué, J., Herman, B., and Lee, D. C. The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell, 56: 465-506, 1989.
16. Mydlo, J. H., Michaeli, J., Cordon-Cardo, C., Goldenberg, A. S., Heston, W. D. W., and Fair, W. R. Expression of transforming growth factor α and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res., 49: 3407-3411, 1989.
17. Dempsey, P. J., and Coffey, R. J. Basolateral targeting and efficient consumption of transforming growth factor-α when expressed in Madin-Darby canine kidney cells. J. Biol. Chem., 269: 16878-16889, 1994.
18. Berkowitz, E. A., Hissong, M. A., and Lee, D. C. Transcriptional and post-transcriptional induction of the TGF-α gene in transformed rat liver epithelial cells. Oncogene, 12: 1991-2002, 1996.
19. Grandis, J. R., Zeng, Q., and Tweardy, D. J. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines. Nat. Med., 2: 237-240, 1996.
20. Gille, J., Swerlick, R. A., and Caughman, S. W. Transforming growth factor-α-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J., 16: 750-759, 1997.
21. Brawerman, G. mRNA degradation in eukaryotic cells: an overview. In: J. G. Belasco and G. Brawerman (eds.), Contol of Messenger RNA Stability, pp. 149-160. San Diego: Academic Press, 1993.
22. Levy, A. P., Levy, N. S., and Goldberg, M. A. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J. Biol. Chem., 271: 25492-25497, 1996.
23. Coffey, R. J., Jr., Graves-Deal, R., Dempsey, P. J., Whitehead, R. H., and Pittelkow, M. R. Differential regulation of transforming growth factor autoinduction in a nontransformed and transformed epithelial cell. Cell Growth Differ., 3: 347-354, 1992.
24. Nicolini, G., Milosi, M., Moroni, M. C., Beguinot, L., and Scotto, L. Post-transcriptional control regulates transforming growth factor alpha in the human carcinoma KB cell line. J. Biol. Chem., 271: 30290-30296, 1996.
25. Pause, A., Lee, S., Worrell, R. A., Chen, D. Y. T., Burgess, W. H., Linehan, W. M., and Klausner, R. D. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. USA. 94: 2156-2161, 1997.